Table 3.
Percent agreement between academic readers and Veridex consensus (VC) overall and according to dataset, disease stage, circulating tumor cell (CTC) count and administration of systemic therapy before blood sample collection
| |
Agreement, % |
|
|
|---|---|---|---|
| Median | Range | P -value | |
|
All |
92 |
69 to 97 |
|
|
Dataset |
|
|
|
| Institute Jules Bordet |
81 |
61 to 97 |
<0.001 |
| Institute Curie |
97 |
73 to 99 |
|
| University of Hamburg |
94 |
69 to 98 |
|
|
Stage |
|
|
|
| M0 |
91 |
70 to 96 |
<0.001 |
| M1 |
98 |
64 to 100 |
|
|
CTC count |
|
|
|
| <5 CTCs |
88 |
66 to 95 |
<0.001 |
| ≥5 CTCs |
97 |
74 to 100 |
|
|
Systemic therapy before blood sample collection |
|
|
|
| No |
92 |
74 to 96 |
<0.001 |
| Yes | 89 | 55 to 97 | |
CTC, circulating tumor cell; M0, Non-metastatic, M1, metastatic.